SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-24-000972
Filing Date
2024-02-26
Accepted
2024-02-26 09:00:21
Documents
14
Period of Report
2024-02-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_022624.htm   iXBRL 8-K 18511
  Complete submission text file 0001171843-24-000972.txt   188678

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE anik-20240224.xsd EX-101.SCH 3006
3 XBRL LABEL FILE anik-20240224_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE anik-20240224_pre.xml EX-101.PRE 22353
15 EXTRACTED XBRL INSTANCE DOCUMENT f8k_022624_htm.xml XML 3496
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14027 | Film No.: 24673775
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)